Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia Schroeder

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|September 21, 2018
Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane StructureJon Ander Nieto-Garai, Bärbel Glass, Carmen Bunn, et al.
BMC Cancer|March 3, 2019
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerCornelia Schroeder, Jan Grell, Claudia Hube-Magg, et al.
BMC Cancer|June 2, 2018
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancerMarie-Christine Heinrich, Cosima Göbel, Martina Kluth, et al.
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|September 21, 2018
Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane StructureJon Ander Nieto-Garai, Bärbel Glass, Carmen Bunn, et al.
BMC Cancer|March 3, 2019
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerCornelia Schroeder, Jan Grell, Claudia Hube-Magg, et al.
BMC Cancer|June 2, 2018
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancerMarie-Christine Heinrich, Cosima Göbel, Martina Kluth, et al.
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
International Journal of Molecular Sciences|February 2, 2017
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate CancerNathaniel Melling, Masoud Rashed, Cornelia Schroeder, et al.
Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Pageof 3